| Literature DB >> 31783907 |
Lotta Hamari1,2, Liisa S Järvelä3, Päivi M Lähteenmäki3, Mikko Arola4, Anna Axelin5,6, Tero Vahlberg7, Sanna Salanterä5,6.
Abstract
OBJECTIVE: To evaluate the effect of active video games in promoting physical activity and motor performance, and reducing fatigue in children with cancer. A randomized controlled trial was conducted. The intervention included playing Nintendo Wii™Fit (Nintendo Co., Ltd., Kyoto, Japan) for 30 min/day for 8 weeks. Physical activity was estimated with accelerometers, physical activity diaries and questionnaires. Movement-ABC2 and PedsQL™ were used to examine motor performance and fatigue. Intervention experiences and fidelity were examined with an interview.Entities:
Keywords: Active video games; Fatigue; Motor performance; Physical activity; Randomized controlled trial
Mesh:
Year: 2019 PMID: 31783907 PMCID: PMC6884892 DOI: 10.1186/s13104-019-4821-z
Source DB: PubMed Journal: BMC Res Notes ISSN: 1756-0500
Fig. 1Participant flow
Descriptive values of the outcome measures
| Intervention group | Control group | ||||
|---|---|---|---|---|---|
| N | Median (min–max) | N | Median (min–max) | ||
| Accelerometer counts/h | |||||
| During the intervention | 12 | 500 (131 to 130) | 18 | 385 (116 to 1012) | 0.63 |
| At 1 year | 10 | 524 (284 to 1381) | 12 | 928 (462 to 1384) | 0.05 |
| Changea | 9 | 212 (− 324 to1064) | 12 | 410 (− 20 to 1087) | 0.22 |
| Active video game playing min/week | 12 | 30 (0 to 280) | 15 | 0 (0 to 300) | 0.18 |
| Physical activity min/day | 12 | 34 (0 to 150) | 16 | 23 (0 to 260) | 0.95 |
| Metabolic equivalents h/week | |||||
| At baseline | 13 | 20 (3 to 55) | 16 | 22 (7 to 92) | |
| After the intervention | 8 | 16 (2 to 52) | 12 | 21 (1 to 92) | |
| Changea | 12 | − 0.34 (− 52 to 33) | 12 | 0 (− 34 to 15) | 0.38 |
| Movement-ABC-2 (percentile) | |||||
| At baseline | 13 | 75 (5 to 99) | 16 | 50 (0 to 99) | |
| After the intervention | 14 | 63 (0 to 95) | 17 | 37 (1 to 98) | |
| Changea | 11 | − 4 (− 47 to 54) | 14 | 0 (− 83 to 45) | 0.77 |
| PedsQL Fatigue scores | |||||
| At baseline | 14 | 67 (35 to 100) | 17 | 60 (39 to 97) | |
| After the intervention | 12 | 67 (40 to 92) | 14 | 66 (47 to 90) | |
| Changea | 12 | 4 (− 35 to 68) | 14 | 6 (− 7 to 64) | 1.00 |
aOnly participants with data at both measurement points were included in the analysis
The baseline characteristics of the study participants
| Study cohort (n = 36) | Intervention group (n = 17) | Control group (n = 19) | |
|---|---|---|---|
| Age at recruitment (years) | |||
| Mean (min–max) | 7.8 (3–16) | 7.8 (3–16) | 7.9 (3–15) |
| Gender (N, female:male) | 10:26 | 5:12 | 5:14 |
| Diagnose | |||
| Acute lymphocytic leukemia (SR:IR:HR) | 17 (8:6:3) | 7 (4:2:1) | 10 (4:4:2) |
| Wilms’ tumor | 2 | 2 | 0 |
| Burkitt lymphoma | 3 | 1 | 2 |
| Non-Hodgkin lymphoma | 5 | 3 | 2 |
| Hodgkin lymphoma | 3 | 1 | 2 |
| Other neoplasm | 6 | 3 | 3 |
| Vincristine/vinblastine during first 3 months from diagnose (mg/sqm) | |||
| Mean (STD) | 10.2 (4.2) | 10.2 (4.0) | 10.1 (4.4) |
| Min–Max | 1.4–17.5 | 3.3–16.2 | 1.4–17.5 |
| Physical therapy (visits during the intervention period) | |||
| Mean (STD) | 3 (2.2) | 2.4 (1.6) | 3.6 (2.6) |
| Min–Max | 0–9 | 1–7 | 0–9 |
| Days admitted (during the intervention period) | |||
| Mean (STD) | 32.7 (13.6) | 30.5 (12.1) | 34.7 (14.8) |
| Min–Max | 10–59 | 12–59 | 10–57 |
| Hospital visits (during the intervention period) | |||
| Mean (STD) | 11.2 (7.2) | 12.5 (7.4) | 10.1 (7.1) |
| Min–Max | 1–35 | 4–35 | 1–26 |
SR standard risk, IR intermediate risk, HR high risk